These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 32631524)
1. Synthesis and anti-proliferative activity of a novel 1,2,3-triazole tethered chalcone acetamide derivatives. Vanaparthi S; Bantu R; Jain N; Janardhan S; Nagarapu L Bioorg Med Chem Lett; 2020 Aug; 30(16):127304. PubMed ID: 32631524 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAF Mohassab AM; Hassan HA; Abdelhamid D; Gouda AM; Youssif BGM; Tateishi H; Fujita M; Otsuka M; Abdel-Aziz M Bioorg Chem; 2021 Jan; 106():104510. PubMed ID: 33279248 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-proliferative activity of fluoro-substituted chalcones. Burmaoglu S; Algul O; Anıl DA; Gobek A; Duran GG; Ersan RH; Duran N Bioorg Med Chem Lett; 2016 Jul; 26(13):3172-3176. PubMed ID: 27217001 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity. Chinthala Y; Thakur S; Tirunagari S; Chinde S; Domatti AK; Arigari NK; K V N S S; Alam S; Jonnala KK; Khan F; Tiwari A; Grover P Eur J Med Chem; 2015 Mar; 93():564-73. PubMed ID: 25743216 [TBL] [Abstract][Full Text] [Related]
5. Green synthesis and anticancer potential of chalcone linked-1,2,3-triazoles. Yadav P; Lal K; Kumar A; Guru SK; Jaglan S; Bhushan S Eur J Med Chem; 2017 Jan; 126():944-953. PubMed ID: 28011424 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents. Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178 [TBL] [Abstract][Full Text] [Related]
7. Rational design, synthesis and anti-proliferative evaluation of novel 1,4-benzoxazine-[1,2,3]triazole hybrids. Bollu R; Palem JD; Bantu R; Guguloth V; Nagarapu L; Polepalli S; Jain N Eur J Med Chem; 2015 Jan; 89():138-46. PubMed ID: 25462234 [TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects. Alswah M; Bayoumi AH; Elgamal K; Elmorsy A; Ihmaid S; Ahmed HEA Molecules; 2017 Dec; 23(1):. PubMed ID: 29280968 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells. Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490 [TBL] [Abstract][Full Text] [Related]
10. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity. Kolundžija B; Marković V; Stanojković T; Joksović L; Matić I; Todorović N; Nikolić M; Joksović MD Bioorg Med Chem Lett; 2014 Jan; 24(1):65-71. PubMed ID: 24332490 [TBL] [Abstract][Full Text] [Related]
11. Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: Synthesis, characterization and anticancer activity. Coskun D; Erkisa M; Ulukaya E; Coskun MF; Ari F Eur J Med Chem; 2017 Aug; 136():212-222. PubMed ID: 28494257 [TBL] [Abstract][Full Text] [Related]
12. 1,2,3-Triazole Tagged 3H-Pyrano[2,3-d]pyrimidine-6-carboxylate Derivatives: Synthesis, in Vitro Cytotoxicity, Molecular Docking and DNA Interaction Studies. Boda SK; Pishka V; Lakshmi PVA; Chinde S; Grover P Chem Biodivers; 2018 Jun; 15(6):e18000101. PubMed ID: 29660245 [TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme. El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967 [TBL] [Abstract][Full Text] [Related]
14. Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives. Ghanaat J; Khalilzadeh MA; Zareyee D Mol Divers; 2021 Feb; 25(1):223-232. PubMed ID: 32067134 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents. Yadagiri B; Holagunda UD; Bantu R; Nagarapu L; Kumar CG; Pombala S; Sridhar B Eur J Med Chem; 2014 May; 79():260-5. PubMed ID: 24742385 [TBL] [Abstract][Full Text] [Related]
16. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity. Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of newer 1,3,4-oxadiazole and 1,2,4-triazole based Topsentin analogues as anti-proliferative agent targeting tubulin. Naaz F; Ahmad F; Lone BA; Pokharel YR; Fuloria NK; Fuloria S; Ravichandran M; Pattabhiraman L; Shafi S; Shahar Yar M Bioorg Chem; 2020 Jan; 95():103519. PubMed ID: 31884140 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3). Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489 [TBL] [Abstract][Full Text] [Related]